… Inhaled corticosteroids (ICSs) are a mainstay of COPD treatment for patients with a history
of exacerbations. Initial studies evaluating their use as monotherapy failed to show an effect …

… The use of inhaled corticosteroids (ICS) in combination with bronchodilators in patients
with COPD has been shown to decrease the rate of disease exacerbations and to improve the …

… In the early 1980s, inhaled formulations of corticosteroids were shown to be highly effective
… admitted to hospital for COPD were already using inhaled corticosteroids (ICS) 3, despite the …

… our updated meta-analysis of trials (… risk of pneumonia with the inhaled corticosteroids
currently available (fluticasone and budesonide). Evidence for any intraclass differences in the risk …

… It was reported that inhaled corticosteroids (ICS) treatment may affect local … the risk of
influenza in patients with asthma remains unclear. This meta-analysis aimed to compare the risk of …

… 4.6 Summary of Long-Term Study Data In summary, long-term inhaled corticosteroids do
not slow the rate of FEV 1 decline in patients with COPD.[51–54] FEV 1 was slightly improved …

… to 2008 using free text terms: inhaled corticosteroids, ICS, chronic obstructive pulmonary …
on the role of inhaled corticosteroids in preventing exacerbations of COPD were reviewed. …

… both the effectiveness and safety of inhaled corticosteroids and long-acting bronchodilators
… type of study designs to evaluate the effectiveness or safety of inhaled corticosteroids and …

… of inhaled corticosteroid confers further improvement in terms of improved bronchoprotection,
especially because a recent metaanalysis of 11 studies of steroid-… of inhaled corticosteroid, …

… , we do not know whether inhaled corticosteroids increase or decrease the risk of this
outcome. There is low‐certainty evidence that inhaled corticosteroids may decrease infections. …